Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer - Malignant Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02497508
What this trial is testing

Nivolumab in Patients With Recurrent Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 33
Not applicableStudy completedNCT00897247
What this trial is testing

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

Who this might be right for
Malignant MesotheliomaPulmonary Complications
Barbara Ann Karmanos Cancer Institute 494
Early research (Phase 1)Looking for participantsNCT06251310
What this trial is testing

SW-682 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMesothelioma, Malignant
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 186
Early research (Phase 1)Active Not RecruitingNCT03228537
What this trial is testing

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaStage I Pleural Diffuse Malignant Mesothelioma AJCC v7+4 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT02535312
What this trial is testing

Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

Who this might be right for
Advanced Malignant Solid NeoplasmAdvanced Peritoneal Malignant MesotheliomaAdvanced Pleural Malignant Mesothelioma+4 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01503177
What this trial is testing

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Recurrent Malignant MesotheliomaStage IA Malignant MesotheliomaStage IB Malignant Mesothelioma+3 more
Mayo Clinic 15
Testing effectiveness (Phase 2)Looking for participantsNCT04969315
What this trial is testing

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

Who this might be right for
Renal Cell CancerCastrate Resistant Prostate CancerNon Small Cell Lung Cancer+1 more
Portage Biotech 35
Testing effectiveness (Phase 2)Study completedNCT01291420
What this trial is testing

Dendritic Cell Vaccination for Patients with Solid Tumors

Who this might be right for
GlioblastomaRenal Cell CarcinomaSarcomas+3 more
University Hospital, Antwerp 48
Early research (Phase 1)Ended earlyNCT02372227
What this trial is testing

Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma

Who this might be right for
Relapsed Malignant Mesothelioma
Verastem, Inc. 21
Large-scale testing (Phase 3)Study completedNCT02349412
What this trial is testing

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

Who this might be right for
Liver CancerAnxiety DisorderDepression+7 more
Alliance for Clinical Trials in Oncology 405
Testing effectiveness (Phase 2)Study completedNCT01085630
What this trial is testing

Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 72
Not applicableLooking for participantsNCT07126509
What this trial is testing

Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma

Who this might be right for
MesotheliomaMesothelioma; LungMesotheliomas Pleural+2 more
University of Chicago 30
Testing effectiveness (Phase 2)UnknownNCT04713761
What this trial is testing

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China 15
Not applicableActive Not RecruitingNCT03269227
What this trial is testing

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 30
Testing effectiveness (Phase 2)Study completedNCT00004183
What this trial is testing

Capecitabine in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Study completedNCT05538572
What this trial is testing

PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerGlioblastomaHead and Neck Squamous Cell Carcinoma+4 more
Prelude Therapeutics Incorporated 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03126630
What this trial is testing

Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma

Who this might be right for
Pleural Malignant Mesothelioma
National Cancer Institute (NCI) 49
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Testing effectiveness (Phase 2)Study completedNCT00334594
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 153
Next Page
30